Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001768304 | SCV002008853 | uncertain significance | not provided | 2020-03-31 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation in a gene for which loss-of-function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004536303 | SCV004109591 | uncertain significance | SAMD9L-related disorder | 2023-09-12 | criteria provided, single submitter | clinical testing | The SAMD9L c.1193_1194insTAAACCTCTCCTATGAGA variant is predicted to result in an in-frame amino acid insertion (p.Leu398_Val399insLysProLeuLeu*). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare, and is listed in ClinVar as uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/1318680/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
St. |
RCV005055173 | SCV005689284 | uncertain significance | Ataxia-pancytopenia syndrome | 2024-07-16 | criteria provided, single submitter | clinical testing | The SAMD9L c.1193_1194insTAAACCTCTCCTATGAGA (p.Leu398_Val399insLysProLeuLeuTer) change inserts 18 nucleotides that results in the creation of a premature stop codon. The functional significance of this variant is currently unknown. This variant has not been reported in individuals with ataxia-pancytopenia syndrome or monosomy 7. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance.? |